|
Volumn 263, Issue 2-3, 1999, Pages 105-108
|
The alkylating agent EEDQ facilitates protease-mediated degradation of the human brain α(2A)-adrenoceptor as revealed by a sequence-specific antibody
a a a |
Author keywords
Human (2A) adrenoceptor
|
Indexed keywords
2 ETHOXY 1(2H) QUINOLINECARBOXYLIC ACID ETHYL ESTER;
ALKYLATING AGENT;
ALPHA 2A ADRENERGIC RECEPTOR;
ANTIBODY;
GUANINE NUCLEOTIDE BINDING PROTEIN;
PROTEINASE;
PROTEINASE INHIBITOR;
RECEPTOR SUBTYPE;
UBIQUITIN;
ALKYLATION;
AMINO ACID SEQUENCE;
ANTIBODY PRODUCTION;
ARTICLE;
BRAIN;
DOT HYBRIDIZATION;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HYDROPHOBICITY;
IMMUNOBLOTTING;
IMMUNOREACTIVITY;
PHOSPHORYLATION;
PRIORITY JOURNAL;
PROTEIN MODIFICATION;
PROTEIN TARGETING;
RECEPTOR DOWN REGULATION;
RECEPTOR INTRINSIC ACTIVITY;
RECEPTOR SOLUBILIZATION;
SEQUENCE HOMOLOGY;
ADRENERGIC ALPHA-ANTAGONISTS;
ALKYLATING AGENTS;
AMINO ACID SEQUENCE;
ANTIBODY SPECIFICITY;
BRAIN;
ENDOPEPTIDASES;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
GLYCOSYLATION;
HUMANS;
IMMUNOGLOBULIN G;
MOLECULAR SEQUENCE DATA;
PEPTIDE FRAGMENTS;
QUINOLINES;
RECEPTORS, ADRENERGIC, ALPHA-2;
|
EID: 0033605711
PISSN: 03043940
EISSN: None
Source Type: Journal
DOI: 10.1016/S0304-3940(99)00118-4 Document Type: Article |
Times cited : (6)
|
References (13)
|